Emergent BioSolutions
EBS
#8133
Rank
ยฃ0.27 B
Marketcap
ยฃ5.34
Share price
3.67%
Change (1 day)
-29.04%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -ยฃ72.12 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are ยฃ0.74 Billion. In 2025 the company made an earning of ยฃ0.10 Billion, an increase over its 2024 earnings that were of -ยฃ54.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ72.12 Million-167.15%
2025 ยฃ0.10 B-297.64%
2024 -ยฃ54.34 Million-88.82%
2023 -ยฃ0.49 Billion242.73%
2022 -ยฃ0.15 Billion-153.8%
2021 ยฃ0.26 B-20.43%
2020 ยฃ0.33 B278.02%
2019 ยฃ87.65 M27.11%
2018 ยฃ68.96 M-27.12%
2017 ยฃ94.62 M17.21%
2016 ยฃ80.73 M0.45%
2015 ยฃ80.37 M73.51%
2014 ยฃ46.32 M41.36%
2013 ยฃ32.77 M35.2%
2012 ยฃ24.23 M0.4%
2011 ยฃ24.14 M-56.46%
2010 ยฃ55.44 M76.73%
2009 ยฃ31.37 M32.94%
2008 ยฃ23.6 M-5.62%
2007 ยฃ25 M
2005 ยฃ36.2 M269.89%
2004 ยฃ9.78 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.21 B-7,362.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.81 B-8,186.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ5.96 B-8,396.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-ยฃ8.85 Million-87.69%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-ยฃ8.42 Million-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.25 Billion 242.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.21 B-1,787.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel